Sandra Bailey & Ors v Glaxosmithkline UK Ltd
Decision date: 8 December 2017
Neutral citation: Neutral citation not available
Court: Court not available
Insurance classification confidence: high
Overall AI summary confidence: medium
Short overview
A short description of the case, material issue, and outcome where supported by the judgment.
AI confidence in this overview: medium
This judgment records case management in mass litigation against GlaxoSmithKline and deals particularly with a Defendant application for security for costs to be paid by the Claimants’ litigation funder, Managed Legal Solutions Ltd (MLS). The court had previously ordered the Claimants to pay the Defendant £30,000 (order dated 28 March 2017) and heard the security-for-costs application in November 2017; the judgment records that it is likely an order for security will be made but does not set out a final quantified security order in the supplied text. A further case management conference was adjourned to 20 February 2018.
Ratio decidendi
The legal reasoning necessary to the outcome, where it can safely be identified from the judgment.
AI confidence in this ratio summary: low
No clear binding ratio can safely be identified from the judgment.
Obiter dicta
Judicial observations that were not necessary to the outcome, where they can safely be identified.
AI confidence in this obiter summary: low
No clear obiter dicta can safely be identified from the judgment.
Warning
The automated summary was prepared from selected parts of a longer judgment; consult the original decision for the complete reasoning. The middle of the judgment was omitted from the judgment, which may omit material findings, reasoning and any final relief on the security-for-costs application.